Dyslipidemia / / edited by Samy I. McFarlane.
Dyslipidemia is a major risk factor for cardiovascular disease, which is the leading cause of morbidity and mortality around the globe, particularly among aging populations. Lipoprotein disorders, frequently encountered by clinicians, require early recognition and treatment. In this book, we assembl...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London, England : : IntechOpen,, 2019. |
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 online resource (180 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603143704498 |
---|---|
ctrlnum |
(CKB)5400000000040475 (NjHacI)995400000000040475 (EXLCZ)995400000000040475 |
collection |
bib_alma |
record_format |
marc |
spelling |
Dyslipidemia / edited by Samy I. McFarlane. London, England : IntechOpen, 2019. 1 online resource (180 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (Worldcat, viewed June 28, 2023). Dyslipidemia is a major risk factor for cardiovascular disease, which is the leading cause of morbidity and mortality around the globe, particularly among aging populations. Lipoprotein disorders, frequently encountered by clinicians, require early recognition and treatment. In this book, we assembled a group of world-renowned scholars in their field to address major areas in lipoprotein disorders that are imminently relevant to clinicians and other healthcare providers. Areas discussed include an overview of lipid metabolism, a complex topic, presented in a simplified and rational way. We also highlight recent developments in the field including dyslipidemias characterized by nontraditional lipid biomarkers. Furthermore, we discuss the pathogenesis of atherosclerosis and the role of dyslipidemia. Other chapters include the assessment of primary and secondary causes of dyslipidemia. Targets for treatment as well as the role of major therapeutic agents including statins and PCSK9 inhibitors are also discussed in light of the most recent guidelines by major international organizations. This is in addition to an overview of lifestyle and dietary modification as well as alternative options for dyslipidemia management. Furthermore, dyslipidemia in special populations is emphasized including various ethnic groups as well as those with HIV disease, chronic kidney disease, among others. The role of adiposity including brown fat together with highlights on lipidomics and dyslipidemias characterized by nontraditional lipid biomarkers is also highlighted. We believe that this volume will serve as a valuable resource, not only for clinicians and other healthcare providers, but for students and research scholars as well. Lipids Metabolism Disorders. 1-83968-005-9 McFarlane, Samy I., editor. |
language |
English |
format |
eBook |
author2 |
McFarlane, Samy I., |
author_facet |
McFarlane, Samy I., |
author2_variant |
s i m si sim |
author2_role |
TeilnehmendeR |
title |
Dyslipidemia / |
spellingShingle |
Dyslipidemia / |
title_full |
Dyslipidemia / edited by Samy I. McFarlane. |
title_fullStr |
Dyslipidemia / edited by Samy I. McFarlane. |
title_full_unstemmed |
Dyslipidemia / edited by Samy I. McFarlane. |
title_auth |
Dyslipidemia / |
title_new |
Dyslipidemia / |
title_sort |
dyslipidemia / |
publisher |
IntechOpen, |
publishDate |
2019 |
physical |
1 online resource (180 pages) |
isbn |
1-83968-005-9 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC632 |
callnumber-sort |
RC 3632 L5 D975 42019 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.3997 |
dewey-sort |
3616.3997 |
dewey-raw |
616.3997 |
dewey-search |
616.3997 |
work_keys_str_mv |
AT mcfarlanesamyi dyslipidemia |
status_str |
n |
ids_txt_mv |
(CKB)5400000000040475 (NjHacI)995400000000040475 (EXLCZ)995400000000040475 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Dyslipidemia / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653194069147648 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02645nam a2200277 i 4500</leader><controlfield tag="001">993603143704498</controlfield><controlfield tag="005">20230628171020.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230628s2019 enk o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040475</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000040475</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040475</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC632.L5</subfield><subfield code="b">.D975 2019</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.3997</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Dyslipidemia /</subfield><subfield code="c">edited by Samy I. McFarlane.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, England :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2019.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (180 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (Worldcat, viewed June 28, 2023).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dyslipidemia is a major risk factor for cardiovascular disease, which is the leading cause of morbidity and mortality around the globe, particularly among aging populations. Lipoprotein disorders, frequently encountered by clinicians, require early recognition and treatment. In this book, we assembled a group of world-renowned scholars in their field to address major areas in lipoprotein disorders that are imminently relevant to clinicians and other healthcare providers. Areas discussed include an overview of lipid metabolism, a complex topic, presented in a simplified and rational way. We also highlight recent developments in the field including dyslipidemias characterized by nontraditional lipid biomarkers. Furthermore, we discuss the pathogenesis of atherosclerosis and the role of dyslipidemia. Other chapters include the assessment of primary and secondary causes of dyslipidemia. Targets for treatment as well as the role of major therapeutic agents including statins and PCSK9 inhibitors are also discussed in light of the most recent guidelines by major international organizations. This is in addition to an overview of lifestyle and dietary modification as well as alternative options for dyslipidemia management. Furthermore, dyslipidemia in special populations is emphasized including various ethnic groups as well as those with HIV disease, chronic kidney disease, among others. The role of adiposity including brown fat together with highlights on lipidomics and dyslipidemias characterized by nontraditional lipid biomarkers is also highlighted. We believe that this volume will serve as a valuable resource, not only for clinicians and other healthcare providers, but for students and research scholars as well.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Lipids</subfield><subfield code="x">Metabolism</subfield><subfield code="x">Disorders.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83968-005-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McFarlane, Samy I.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:06:16 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338032030004498&Force_direct=true</subfield><subfield code="Z">5338032030004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338032030004498</subfield></datafield></record></collection> |